ASRT

Assertio Holdings, Inc. (NASDAQ:ASRT) is a specialty pharmaceutical company founded in 1995 and headquartered in Lake Forest, Illinois. The company went public in 1997 and has undergone significant transformation over the years, including a name change from Assertio Therapeutics in May 2020. Assertio focuses on developing and commercializing medicines primarily in the areas of neurology, hospital care, and pain and inflammation management. The company has evolved from a broader pharmaceutical operation to a more focused specialty player, currently managing a portfolio of established products while seeking strategic growth opportunities through acquisitions and product development.